img

Global Idiopathic Hypersomnia Treatment Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Idiopathic Hypersomnia Treatment Market Insights, Forecast to 2034

Idiopathic hypersomnia (IH) is a rare sleep disorder marked by an over sleeping duration time during the day even after a longer sleeping hours of night sleep. People with idiopathic hypersomnia sleep normal or for long hours each night but still feel excessively sleepy during the day. Idiopathic hypersomnia is a type of hypersomnia and symptoms include chronic excessive daytime sleepiness (EDS), non-refreshing daytime napping, sleep drunkenness after nighttime sleep, naps, and others. Idiopathic hypersomnia is a nervous system disease, whose cause is not known. There is no single drug available that is approved by the U.S. FDA for this disease, but medicines such as dextroamphetamine that are approved for narcolepsy, one of the types of hypersomnia can be used for idiopathic hypersomnia off-label.
Market Analysis and InsightsGlobal Idiopathic Hypersomnia Treatment Market
Global Idiopathic Hypersomnia Treatment market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Idiopathic Hypersomnia Treatment industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Idiopathic Hypersomnia Treatment market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Idiopathic Hypersomnia Treatment market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Takeda Pharmaceutical
Teva Pharmaceutical Industries
Jazz Pharmaceuticals
BIOPROJET
Avadel Pharmaceuticals
GlaxoSmithKline
Pfizer
Theranexus
Fisher and Paykel Healthcare
Drive DeVilbiss Healthcare
Merck
Segment by Type
Stimulant Medications
Non-Stimulant Wake-Promoting Medications
Sodium Oxybate

Segment by Application


Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Idiopathic Hypersomnia Treatment introduction, etc. Idiopathic Hypersomnia Treatment Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Idiopathic Hypersomnia Treatment
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Idiopathic Hypersomnia Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Stimulant Medications
1.2.3 Non-Stimulant Wake-Promoting Medications
1.2.4 Sodium Oxybate
1.3 Market by Application
1.3.1 Global Idiopathic Hypersomnia Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Idiopathic Hypersomnia Treatment Market Perspective (2018-2029)
2.2 Global Idiopathic Hypersomnia Treatment Growth Trends by Region
2.2.1 Idiopathic Hypersomnia Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Idiopathic Hypersomnia Treatment Historic Market Size by Region (2018-2024)
2.2.3 Idiopathic Hypersomnia Treatment Forecasted Market Size by Region (2024-2029)
2.3 Idiopathic Hypersomnia Treatment Market Dynamics
2.3.1 Idiopathic Hypersomnia Treatment Industry Trends
2.3.2 Idiopathic Hypersomnia Treatment Market Drivers
2.3.3 Idiopathic Hypersomnia Treatment Market Challenges
2.3.4 Idiopathic Hypersomnia Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Idiopathic Hypersomnia Treatment by Players
3.1.1 Global Idiopathic Hypersomnia Treatment Revenue by Players (2018-2024)
3.1.2 Global Idiopathic Hypersomnia Treatment Revenue Market Share by Players (2018-2024)
3.2 Global Idiopathic Hypersomnia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Idiopathic Hypersomnia Treatment, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Idiopathic Hypersomnia Treatment Market Concentration Ratio
3.4.1 Global Idiopathic Hypersomnia Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Idiopathic Hypersomnia Treatment Revenue in 2022
3.5 Global Key Players of Idiopathic Hypersomnia Treatment Head office and Area Served
3.6 Global Key Players of Idiopathic Hypersomnia Treatment, Product and Application
3.7 Global Key Players of Idiopathic Hypersomnia Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Idiopathic Hypersomnia Treatment Breakdown Data by Type
4.1 Global Idiopathic Hypersomnia Treatment Historic Market Size by Type (2018-2024)
4.2 Global Idiopathic Hypersomnia Treatment Forecasted Market Size by Type (2024-2029)
5 Idiopathic Hypersomnia Treatment Breakdown Data by Application
5.1 Global Idiopathic Hypersomnia Treatment Historic Market Size by Application (2018-2024)
5.2 Global Idiopathic Hypersomnia Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Idiopathic Hypersomnia Treatment Market Size (2018-2029)
6.2 North America Idiopathic Hypersomnia Treatment Market Size by Type
6.2.1 North America Idiopathic Hypersomnia Treatment Market Size by Type (2018-2024)
6.2.2 North America Idiopathic Hypersomnia Treatment Market Size by Type (2024-2029)
6.2.3 North America Idiopathic Hypersomnia Treatment Market Share by Type (2018-2029)
6.3 North America Idiopathic Hypersomnia Treatment Market Size by Application
6.3.1 North America Idiopathic Hypersomnia Treatment Market Size by Application (2018-2024)
6.3.2 North America Idiopathic Hypersomnia Treatment Market Size by Application (2024-2029)
6.3.3 North America Idiopathic Hypersomnia Treatment Market Share by Application (2018-2029)
6.4 North America Idiopathic Hypersomnia Treatment Market Size by Country
6.4.1 North America Idiopathic Hypersomnia Treatment Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Idiopathic Hypersomnia Treatment Market Size by Country (2018-2024)
6.4.3 North America Idiopathic Hypersomnia Treatment Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Idiopathic Hypersomnia Treatment Market Size (2018-2029)
7.2 Europe Idiopathic Hypersomnia Treatment Market Size by Type
7.2.1 Europe Idiopathic Hypersomnia Treatment Market Size by Type (2018-2024)
7.2.2 Europe Idiopathic Hypersomnia Treatment Market Size by Type (2024-2029)
7.2.3 Europe Idiopathic Hypersomnia Treatment Market Share by Type (2018-2029)
7.3 Europe Idiopathic Hypersomnia Treatment Market Size by Application
7.3.1 Europe Idiopathic Hypersomnia Treatment Market Size by Application (2018-2024)
7.3.2 Europe Idiopathic Hypersomnia Treatment Market Size by Application (2024-2029)
7.3.3 Europe Idiopathic Hypersomnia Treatment Market Share by Application (2018-2029)
7.4 Europe Idiopathic Hypersomnia Treatment Market Size by Country
7.4.1 Europe Idiopathic Hypersomnia Treatment Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Idiopathic Hypersomnia Treatment Market Size by Country (2018-2024)
7.4.3 Europe Idiopathic Hypersomnia Treatment Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Idiopathic Hypersomnia Treatment Market Size (2018-2029)
8.2 China Idiopathic Hypersomnia Treatment Market Size by Type
8.2.1 China Idiopathic Hypersomnia Treatment Market Size by Type (2018-2024)
8.2.2 China Idiopathic Hypersomnia Treatment Market Size by Type (2024-2029)
8.2.3 China Idiopathic Hypersomnia Treatment Market Share by Type (2018-2029)
8.3 China Idiopathic Hypersomnia Treatment Market Size by Application
8.3.1 China Idiopathic Hypersomnia Treatment Market Size by Application (2018-2024)
8.3.2 China Idiopathic Hypersomnia Treatment Market Size by Application (2024-2029)
8.3.3 China Idiopathic Hypersomnia Treatment Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Idiopathic Hypersomnia Treatment Market Size (2018-2029)
9.2 Asia Idiopathic Hypersomnia Treatment Market Size by Type
9.2.1 Asia Idiopathic Hypersomnia Treatment Market Size by Type (2018-2024)
9.2.2 Asia Idiopathic Hypersomnia Treatment Market Size by Type (2024-2029)
9.2.3 Asia Idiopathic Hypersomnia Treatment Market Share by Type (2018-2029)
9.3 Asia Idiopathic Hypersomnia Treatment Market Size by Application
9.3.1 Asia Idiopathic Hypersomnia Treatment Market Size by Application (2018-2024)
9.3.2 Asia Idiopathic Hypersomnia Treatment Market Size by Application (2024-2029)
9.3.3 Asia Idiopathic Hypersomnia Treatment Market Share by Application (2018-2029)
9.4 Asia Idiopathic Hypersomnia Treatment Market Size by Region
9.4.1 Asia Idiopathic Hypersomnia Treatment Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Idiopathic Hypersomnia Treatment Market Size by Region (2018-2024)
9.4.3 Asia Idiopathic Hypersomnia Treatment Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Takeda Pharmaceutical
11.1.1 Takeda Pharmaceutical Company Details
11.1.2 Takeda Pharmaceutical Business Overview
11.1.3 Takeda Pharmaceutical Idiopathic Hypersomnia Treatment Introduction
11.1.4 Takeda Pharmaceutical Revenue in Idiopathic Hypersomnia Treatment Business (2018-2024)
11.1.5 Takeda Pharmaceutical Recent Developments
11.2 Teva Pharmaceutical Industries
11.2.1 Teva Pharmaceutical Industries Company Details
11.2.2 Teva Pharmaceutical Industries Business Overview
11.2.3 Teva Pharmaceutical Industries Idiopathic Hypersomnia Treatment Introduction
11.2.4 Teva Pharmaceutical Industries Revenue in Idiopathic Hypersomnia Treatment Business (2018-2024)
11.2.5 Teva Pharmaceutical Industries Recent Developments
11.3 Jazz Pharmaceuticals
11.3.1 Jazz Pharmaceuticals Company Details
11.3.2 Jazz Pharmaceuticals Business Overview
11.3.3 Jazz Pharmaceuticals Idiopathic Hypersomnia Treatment Introduction
11.3.4 Jazz Pharmaceuticals Revenue in Idiopathic Hypersomnia Treatment Business (2018-2024)
11.3.5 Jazz Pharmaceuticals Recent Developments
11.4 BIOPROJET
11.4.1 BIOPROJET Company Details
11.4.2 BIOPROJET Business Overview
11.4.3 BIOPROJET Idiopathic Hypersomnia Treatment Introduction
11.4.4 BIOPROJET Revenue in Idiopathic Hypersomnia Treatment Business (2018-2024)
11.4.5 BIOPROJET Recent Developments
11.5 Avadel Pharmaceuticals
11.5.1 Avadel Pharmaceuticals Company Details
11.5.2 Avadel Pharmaceuticals Business Overview
11.5.3 Avadel Pharmaceuticals Idiopathic Hypersomnia Treatment Introduction
11.5.4 Avadel Pharmaceuticals Revenue in Idiopathic Hypersomnia Treatment Business (2018-2024)
11.5.5 Avadel Pharmaceuticals Recent Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Idiopathic Hypersomnia Treatment Introduction
11.6.4 GlaxoSmithKline Revenue in Idiopathic Hypersomnia Treatment Business (2018-2024)
11.6.5 GlaxoSmithKline Recent Developments
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Idiopathic Hypersomnia Treatment Introduction
11.7.4 Pfizer Revenue in Idiopathic Hypersomnia Treatment Business (2018-2024)
11.7.5 Pfizer Recent Developments
11.8 Theranexus
11.8.1 Theranexus Company Details
11.8.2 Theranexus Business Overview
11.8.3 Theranexus Idiopathic Hypersomnia Treatment Introduction
11.8.4 Theranexus Revenue in Idiopathic Hypersomnia Treatment Business (2018-2024)
11.8.5 Theranexus Recent Developments
11.9 Fisher and Paykel Healthcare
11.9.1 Fisher and Paykel Healthcare Company Details
11.9.2 Fisher and Paykel Healthcare Business Overview
11.9.3 Fisher and Paykel Healthcare Idiopathic Hypersomnia Treatment Introduction
11.9.4 Fisher and Paykel Healthcare Revenue in Idiopathic Hypersomnia Treatment Business (2018-2024)
11.9.5 Fisher and Paykel Healthcare Recent Developments
11.10 Drive DeVilbiss Healthcare
11.10.1 Drive DeVilbiss Healthcare Company Details
11.10.2 Drive DeVilbiss Healthcare Business Overview
11.10.3 Drive DeVilbiss Healthcare Idiopathic Hypersomnia Treatment Introduction
11.10.4 Drive DeVilbiss Healthcare Revenue in Idiopathic Hypersomnia Treatment Business (2018-2024)
11.10.5 Drive DeVilbiss Healthcare Recent Developments
11.11 Merck
11.11.1 Merck Company Details
11.11.2 Merck Business Overview
11.11.3 Merck Idiopathic Hypersomnia Treatment Introduction
11.11.4 Merck Revenue in Idiopathic Hypersomnia Treatment Business (2018-2024)
11.11.5 Merck Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Idiopathic Hypersomnia Treatment Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Stimulant Medications
Table 3. Key Players of Non-Stimulant Wake-Promoting Medications
Table 4. Key Players of Sodium Oxybate
Table 5. Global Idiopathic Hypersomnia Treatment Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global Idiopathic Hypersomnia Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Idiopathic Hypersomnia Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Idiopathic Hypersomnia Treatment Market Share by Region (2018-2024)
Table 9. Global Idiopathic Hypersomnia Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Idiopathic Hypersomnia Treatment Market Share by Region (2024-2029)
Table 11. Idiopathic Hypersomnia Treatment Market Trends
Table 12. Idiopathic Hypersomnia Treatment Market Drivers
Table 13. Idiopathic Hypersomnia Treatment Market Challenges
Table 14. Idiopathic Hypersomnia Treatment Market Restraints
Table 15. Global Idiopathic Hypersomnia Treatment Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Idiopathic Hypersomnia Treatment Revenue Share by Players (2018-2024)
Table 17. Global Top Idiopathic Hypersomnia Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Idiopathic Hypersomnia Treatment as of 2022)
Table 18. Global Idiopathic Hypersomnia Treatment Industry Ranking 2021 VS 2022 VS 2024
Table 19. Global 5 Largest Players Market Share by Idiopathic Hypersomnia Treatment Revenue (CR5 and HHI) & (2018-2024)
Table 20. Global Key Players of Idiopathic Hypersomnia Treatment, Headquarters and Area Served
Table 21. Global Key Players of Idiopathic Hypersomnia Treatment, Product and Application
Table 22. Global Key Players of Idiopathic Hypersomnia Treatment, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Idiopathic Hypersomnia Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Idiopathic Hypersomnia Treatment Revenue Market Share by Type (2018-2024)
Table 26. Global Idiopathic Hypersomnia Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Idiopathic Hypersomnia Treatment Revenue Market Share by Type (2024-2029)
Table 28. Global Idiopathic Hypersomnia Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Idiopathic Hypersomnia Treatment Revenue Share by Application (2018-2024)
Table 30. Global Idiopathic Hypersomnia Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Idiopathic Hypersomnia Treatment Revenue Share by Application (2024-2029)
Table 32. North America Idiopathic Hypersomnia Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 33. North America Idiopathic Hypersomnia Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America Idiopathic Hypersomnia Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 35. North America Idiopathic Hypersomnia Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America Idiopathic Hypersomnia Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Idiopathic Hypersomnia Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 38. North America Idiopathic Hypersomnia Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Idiopathic Hypersomnia Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 40. Europe Idiopathic Hypersomnia Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe Idiopathic Hypersomnia Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 42. Europe Idiopathic Hypersomnia Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe Idiopathic Hypersomnia Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe Idiopathic Hypersomnia Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 45. Europe Idiopathic Hypersomnia Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 46. China Idiopathic Hypersomnia Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 47. China Idiopathic Hypersomnia Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 48. China Idiopathic Hypersomnia Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 49. China Idiopathic Hypersomnia Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia Idiopathic Hypersomnia Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 51. Asia Idiopathic Hypersomnia Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia Idiopathic Hypersomnia Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 53. Asia Idiopathic Hypersomnia Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Idiopathic Hypersomnia Treatment Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia Idiopathic Hypersomnia Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 56. Asia Idiopathic Hypersomnia Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 64. Takeda Pharmaceutical Company Details
Table 65. Takeda Pharmaceutical Business Overview
Table 66. Takeda Pharmaceutical Idiopathic Hypersomnia Treatment Product
Table 67. Takeda Pharmaceutical Revenue in Idiopathic Hypersomnia Treatment Business (2018-2024) & (US$ Million)
Table 68. Takeda Pharmaceutical Recent Developments
Table 69. Teva Pharmaceutical Industries Company Details
Table 70. Teva Pharmaceutical Industries Business Overview
Table 71. Teva Pharmaceutical Industries Idiopathic Hypersomnia Treatment Product
Table 72. Teva Pharmaceutical Industries Revenue in Idiopathic Hypersomnia Treatment Business (2018-2024) & (US$ Million)
Table 73. Teva Pharmaceutical Industries Recent Developments
Table 74. Jazz Pharmaceuticals Company Details
Table 75. Jazz Pharmaceuticals Business Overview
Table 76. Jazz Pharmaceuticals Idiopathic Hypersomnia Treatment Product
Table 77. Jazz Pharmaceuticals Revenue in Idiopathic Hypersomnia Treatment Business (2018-2024) & (US$ Million)
Table 78. Jazz Pharmaceuticals Recent Developments
Table 79. BIOPROJET Company Details
Table 80. BIOPROJET Business Overview
Table 81. BIOPROJET Idiopathic Hypersomnia Treatment Product
Table 82. BIOPROJET Revenue in Idiopathic Hypersomnia Treatment Business (2018-2024) & (US$ Million)
Table 83. BIOPROJET Recent Developments
Table 84. Avadel Pharmaceuticals Company Details
Table 85. Avadel Pharmaceuticals Business Overview
Table 86. Avadel Pharmaceuticals Idiopathic Hypersomnia Treatment Product
Table 87. Avadel Pharmaceuticals Revenue in Idiopathic Hypersomnia Treatment Business (2018-2024) & (US$ Million)
Table 88. Avadel Pharmaceuticals Recent Developments
Table 89. GlaxoSmithKline Company Details
Table 90. GlaxoSmithKline Business Overview
Table 91. GlaxoSmithKline Idiopathic Hypersomnia Treatment Product
Table 92. GlaxoSmithKline Revenue in Idiopathic Hypersomnia Treatment Business (2018-2024) & (US$ Million)
Table 93. GlaxoSmithKline Recent Developments
Table 94. Pfizer Company Details
Table 95. Pfizer Business Overview
Table 96. Pfizer Idiopathic Hypersomnia Treatment Product
Table 97. Pfizer Revenue in Idiopathic Hypersomnia Treatment Business (2018-2024) & (US$ Million)
Table 98. Pfizer Recent Developments
Table 99. Theranexus Company Details
Table 100. Theranexus Business Overview
Table 101. Theranexus Idiopathic Hypersomnia Treatment Product
Table 102. Theranexus Revenue in Idiopathic Hypersomnia Treatment Business (2018-2024) & (US$ Million)
Table 103. Theranexus Recent Developments
Table 104. Fisher and Paykel Healthcare Company Details
Table 105. Fisher and Paykel Healthcare Business Overview
Table 106. Fisher and Paykel Healthcare Idiopathic Hypersomnia Treatment Product
Table 107. Fisher and Paykel Healthcare Revenue in Idiopathic Hypersomnia Treatment Business (2018-2024) & (US$ Million)
Table 108. Fisher and Paykel Healthcare Recent Developments
Table 109. Drive DeVilbiss Healthcare Company Details
Table 110. Drive DeVilbiss Healthcare Business Overview
Table 111. Drive DeVilbiss Healthcare Idiopathic Hypersomnia Treatment Product
Table 112. Drive DeVilbiss Healthcare Revenue in Idiopathic Hypersomnia Treatment Business (2018-2024) & (US$ Million)
Table 113. Drive DeVilbiss Healthcare Recent Developments
Table 114. Merck Company Details
Table 115. Merck Business Overview
Table 116. Merck Idiopathic Hypersomnia Treatment Product
Table 117. Merck Revenue in Idiopathic Hypersomnia Treatment Business (2018-2024) & (US$ Million)
Table 118. Merck Recent Developments
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Idiopathic Hypersomnia Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Idiopathic Hypersomnia Treatment Market Share by Type: 2022 VS 2029
Figure 3. Stimulant Medications Features
Figure 4. Non-Stimulant Wake-Promoting Medications Features
Figure 5. Sodium Oxybate Features
Figure 6. Global Idiopathic Hypersomnia Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Idiopathic Hypersomnia Treatment Market Share by Application: 2022 VS 2029
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Idiopathic Hypersomnia Treatment Report Years Considered
Figure 12. Global Idiopathic Hypersomnia Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Idiopathic Hypersomnia Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Idiopathic Hypersomnia Treatment Market Share by Region: 2022 VS 2029
Figure 15. Global Idiopathic Hypersomnia Treatment Market Share by Players in 2022
Figure 16. Global Top Idiopathic Hypersomnia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Idiopathic Hypersomnia Treatment as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Idiopathic Hypersomnia Treatment Revenue in 2022
Figure 18. North America Idiopathic Hypersomnia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Idiopathic Hypersomnia Treatment Market Share by Type (2018-2029)
Figure 20. North America Idiopathic Hypersomnia Treatment Market Share by Application (2018-2029)
Figure 21. North America Idiopathic Hypersomnia Treatment Market Share by Country (2018-2029)
Figure 22. United States Idiopathic Hypersomnia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Canada Idiopathic Hypersomnia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Idiopathic Hypersomnia Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 25. Europe Idiopathic Hypersomnia Treatment Market Share by Type (2018-2029)
Figure 26. Europe Idiopathic Hypersomnia Treatment Market Share by Application (2018-2029)
Figure 27. Europe Idiopathic Hypersomnia Treatment Market Share by Country (2018-2029)
Figure 28. Germany Idiopathic Hypersomnia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. France Idiopathic Hypersomnia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. U.K. Idiopathic Hypersomnia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Italy Idiopathic Hypersomnia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Russia Idiopathic Hypersomnia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Nordic Countries Idiopathic Hypersomnia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. China Idiopathic Hypersomnia Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 35. China Idiopathic Hypersomnia Treatment Market Share by Type (2018-2029)
Figure 36. China Idiopathic Hypersomnia Treatment Market Share by Application (2018-2029)
Figure 37. Asia Idiopathic Hypersomnia Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 38. Asia Idiopathic Hypersomnia Treatment Market Share by Type (2018-2029)
Figure 39. Asia Idiopathic Hypersomnia Treatment Market Share by Application (2018-2029)
Figure 40. Asia Idiopathic Hypersomnia Treatment Market Share by Region (2018-2029)
Figure 41. Japan Idiopathic Hypersomnia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. South Korea Idiopathic Hypersomnia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. China Taiwan Idiopathic Hypersomnia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Southeast Asia Idiopathic Hypersomnia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. India Idiopathic Hypersomnia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Australia Idiopathic Hypersomnia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Market Share by Type (2018-2029)
Figure 49. Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Market Share by Application (2018-2029)
Figure 50. Middle East, Africa, and Latin America Idiopathic Hypersomnia Treatment Market Share by Country (2018-2029)
Figure 51. Brazil Idiopathic Hypersomnia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Mexico Idiopathic Hypersomnia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Turkey Idiopathic Hypersomnia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia Idiopathic Hypersomnia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Israel Idiopathic Hypersomnia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. GCC Countries Idiopathic Hypersomnia Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Takeda Pharmaceutical Revenue Growth Rate in Idiopathic Hypersomnia Treatment Business (2018-2024)
Figure 58. Teva Pharmaceutical Industries Revenue Growth Rate in Idiopathic Hypersomnia Treatment Business (2018-2024)
Figure 59. Jazz Pharmaceuticals Revenue Growth Rate in Idiopathic Hypersomnia Treatment Business (2018-2024)
Figure 60. BIOPROJET Revenue Growth Rate in Idiopathic Hypersomnia Treatment Business (2018-2024)
Figure 61. Avadel Pharmaceuticals Revenue Growth Rate in Idiopathic Hypersomnia Treatment Business (2018-2024)
Figure 62. GlaxoSmithKline Revenue Growth Rate in Idiopathic Hypersomnia Treatment Business (2018-2024)
Figure 63. Pfizer Revenue Growth Rate in Idiopathic Hypersomnia Treatment Business (2018-2024)
Figure 64. Theranexus Revenue Growth Rate in Idiopathic Hypersomnia Treatment Business (2018-2024)
Figure 65. Fisher and Paykel Healthcare Revenue Growth Rate in Idiopathic Hypersomnia Treatment Business (2018-2024)
Figure 66. Drive DeVilbiss Healthcare Revenue Growth Rate in Idiopathic Hypersomnia Treatment Business (2018-2024)
Figure 67. Merck Revenue Growth Rate in Idiopathic Hypersomnia Treatment Business (2018-2024)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries